Apellis Pharmaceuticals Inc (APLS) short volume · rev $1.00B
Apellis Pharmaceuticals Inc FINRA short-volume cache. Latest 2026-05-13.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-05-13 | 8,148,770 | 16,135,110 | 50.5% |
| 2026-05-12 | 1,153,840 | 2,679,383 | 43.1% |
| 2026-05-11 | 1,316,375 | 2,808,416 | 46.9% |
| 2026-05-08 | 712,838 | 1,855,612 | 38.4% |
| 2026-05-07 | 667,308 | 2,136,574 | 31.2% |
| 2026-05-06 | 349,433 | 850,755 | 41.1% |
| 2026-05-05 | 115,396 | 438,353 | 26.3% |
| 2026-05-04 | 221,542 | 594,794 | 37.2% |
| 2026-05-01 | 119,139 | 286,527 | 41.6% |
| 2026-04-30 | 254,195 | 497,791 | 51.1% |
APLS short volume FAQ
What was APLS's latest FINRA short volume?
On May 13, 2026, cached FINRA short volume for Apellis Pharmaceuticals Inc (APLS) was 8,148,770 shares, 50.5% of 16,135,110 total volume.
How many APLS short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Apellis Pharmaceuticals Inc (APLS), from Apr 30, 2026 through May 13, 2026.
How did APLS short volume percent change from the prior cached session?
Cached FINRA short volume for Apellis Pharmaceuticals Inc (APLS) moved from 43.1% on May 12, 2026 to 50.5% on May 13, 2026, up 7.4 percentage points.
What was the highest APLS short volume percent on this page?
The highest cached FINRA short volume on this page is 51.1% of total volume on Apr 30, 2026.
What is APLS's latest revenue?
Latest cached Apellis Pharmaceuticals Inc (APLS) revenue for Dec 31, 2025 was $1.00B. Statements: https://lician.com/financials/apls
What is the average APLS short volume percent on this page?
Across 10 cached sessions on this page, Apellis Pharmaceuticals Inc (APLS) short volume averaged 40.7% of total volume.
Where is APLS short volume listed?
Cached FINRA short volume for Apellis Pharmaceuticals Inc (APLS) is listed at https://lician.com/short-interest/apls.
Not investment advice. Cached rows, not a live tape.